The prognostic significance of derivative chromosome 9 deletions in Chinese patients with chronic myelogenous leukemia

被引：0
|
作者：
Li, Jian-Yong [1 ]
Xu, Wei [1 ]
Wu, Wei [1 ]
Zhu, Yu [1 ]
Qiu, Hai-Rong [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2007年 / 29卷
关键词：
D O I：
10.1504/IJCAT.2007.015244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] The poor prognostic significance of deletions of derivative chromosome 9 in Chinese patients with chronic myelogenous leukemia
    Li, J.
    Xu, W.
    Wu, W.
    Zhang, S.
    Zhu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia
    Kreil, Sebastian
    Pfirrmann, Markus
    Haferlach, Claudia
    Waghorn, Katherine
    Chase, Andrew
    Hehlmann, Ruediger
    Reiter, Andreas
    Hochhaus, Andreas
    Cross, Nicholas C. P.
    BLOOD, 2007, 110 (04) : 1283 - 1290
  • [3] Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia
    Quintas-Cardama, A
    Kantarjian, H
    Talpaz, M
    O'Brien, S
    Garcia-Manero, G
    Verstovsek, S
    Rios, MB
    Hayes, K
    Glassman, A
    Bekele, BN
    Zhou, M
    Cortes, J
    BLOOD, 2005, 105 (06) : 2281 - 2286
  • [4] Prognostic Impact of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia Treated With Nilotinib or Dasatinib
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Shan, Jianqin
    Jabbour, Elias
    Abruzzo, Lynne V.
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Cortes, Jorge
    CANCER, 2011, 117 (22) : 5085 - 5093
  • [5] Prognostic Implications of Derivative Chromosome 9 Deletions in Patients with Advanced-Stage Chronic Myelogenous Leukemia
    Chandran, Ramachandran Krishna
    Geetha, Narayanan
    Sakthivel, Kunnathur Murugesan
    Aswathy, Chandran Geetha
    Gopinath, Preethi
    Nair, Jagathnath Krishna Kumarapillai Mohanan
    Sreedharan, Hariharan
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2018, 37 (02) : 117 - 126
  • [6] Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukaemia
    Kreil, S.
    Pfirrmann, M.
    Waghorn, K.
    Chase, A.
    Hehlmann, R.
    Reiter, A.
    Hochhaus, A.
    Cross, N. C. P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 24 - 24
  • [7] Prognostic Impact of Deletions of Derivative Chromosome 9 on Patients (PTS) with Chronic Myelogenous Leukemia (CML) in Chronic Phase Treated with Nilotinib or Dasatinib
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop M.
    O'Brien, Susan
    Borthakur, Gautam
    Verstovsek, Srdan
    Wierda, William
    Shan, Jenny
    Cortes, Jorge
    BLOOD, 2008, 112 (11) : 734 - 735
  • [8] Prognostic impact of deletions of derivative chromosome 9 on patients (pts) with chronic myelogenous leukemia (CML) in chronic phase treated with nilotinib or dasatinib
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Thomas, Deborah
    Koller, Charles
    Shan, Jenny
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 581A - 581A
  • [9] The Negative Prognostic Impact of Derivative 9 Deletions in Patients Who Received Hydroxyurea Treatment for Chronic Myelogenous Leukemia in the Chronic Phase
    Li, Jian-Yong
    Xu, Wei
    Wu, Wei
    Zhu, Yu
    Qiu, Hai-Rong
    Zhang, Run
    Zhang, Su-Jiang
    Qian, Si-Xuan
    ONKOLOGIE, 2008, 31 (11): : 585 - 589
  • [10] High incidence of derivative chromosome arm 9q deletions in Asian chronic myelogenous leukemia
    Tien, SL
    Rudduck-Sivaswaren, C
    Lim, P
    Lim, E
    Lie, DKH
    Tan, PHC
    Lee, ASG
    GENES CHROMOSOMES & CANCER, 2005, 42 (04): : 433 - 434
12345